Condition

Cytomegalovirus (CMV) clinical trials and research

• 7Clinical trials
• 14Countries

Newest Cytomegalovirus (CMV) clinical trials

All recruiting trials (7)

• Maribavir for CMV in people with lymphoma or multiple myeloma receiving bispecific antibodies

  This will test whether the oral antiviral maribavir can treat CMV reactivation in adults with lymphoma or multiple myeloma who are receiving bispecific antibody therapy.

  Recruiting Phase 2 Seoul National University Hospital · Seoul · NCT07014319

• Preventing CMV after receiving a CMV-positive donor kidney using daily antiviral pills or weekly blood monitoring

  This study will test whether taking daily antiviral pills for 200 days or doing weekly blood checks and treating only if the virus appears is better at preventing CMV disease in adults who get a kidney from a CMV-positive donor and are themselves CMV-negative.

  Recruiting at 6 sites Phase 3 University of California, San Francisco · San Francisco, California and 7 other locations · NCT06798909

• Comparing tests for diagnosing cytomegalovirus in patients with inflammatory bowel disease

  This study is testing different ways to diagnose cytomegalovirus in adults with inflammatory bowel disease who are having worse symptoms and need to be hospitalized.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT06793124

• Survey of Maribavir tablets for treating Cytomegalovirus infection

  This study is testing if Maribavir tablets can help people with Cytomegalovirus infection who haven't responded to other treatments, especially those who have had an organ transplant.

  Recruiting Takeda · Tokyo, Tokyo · NCT06577363

• Evaluating LIVTENCITY for treating CMV infection in transplant patients in South Korea

  This study is testing if LIVTENCITY can safely and effectively treat cytomegalovirus (CMV) infection in adults who have had a transplant and haven't had success with other treatments.

  Recruiting Takeda · Seoul · NCT06555432

• Maribavir for CMV in adults with kidney failure after transplantation

  This project will see if maribavir is safe for adults with severe kidney failure (including people on dialysis) who develop CMV after a transplant by reviewing existing medical records.

  Recruiting at 9 sites Takeda · Anderlecht, Brussels Capital and 24 other locations · NCT06243731

• Maribavir treatment for CMV infection in children and adolescents after stem cell or organ transplant

  This study tests whether maribavir is safe and works to treat CMV infection in children and teenagers who have had a stem cell or solid organ transplant.

  Recruiting at 53 sites Phase 3 Takeda · Wilmington, Delaware and 52 other locations · NCT05319353

Related topics

Quick answers

How many Cytomegalovirus (CMV) clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 14 countries. The most sites are in United States (2 trials), Belgium (2 trials), France (2 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →